Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Medicaid Expansion Under the Affordable Care Act and Association With Cardiac Care: A Systematic ReviewGinger Y Jiang, John W Urwin, Jason H WasfyEuropean Heart Journal. Case Reports|March 18, 2021
Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case reportGinger Y Jiang, Qizhe Cai, E Wilson Grandin, et al.Biological Psychiatry|May 1, 2012
Learning and memory depend on fibroblast growth factor receptor 2 functioning in hippocampusHanna E Stevens, Ginger Y Jiang, Michael L Schwartz, et al.The American Journal of Cardiology|July 20, 2024
Who Should Undergo Chronic Total Occlusions Percutaneous Coronary Intervention and When?: An Evidence-Based Approach to the Patient Referred for Percutaneous Coronary Intervention of Chronic Total OcclusionKevin Soriano, Ginger Y Jiang, Lauren Balkan, et al.Journal of Cardiac Failure|September 15, 2023
IV Diuresis in Alternative Treatment Settings for the Management of Heart Failure: Implications for Mortality, Hospitalizations and CostGinger Y Jiang, Christopher Lee, Stephen A Kearing, et al.The American Journal of Cardiology|September 13, 2022
Mitral Regurgitation and Mortality Risk in Medicare Beneficiaries With Heart Failure and Preserved Ejection FractionGinger Y Jiang, Jiaman Xu, Warren J Manning, et al.JAMA Cardiology|February 20, 2020
Performance in Federal Value-Based Programs of Hospitals Recognized by the American Heart Association and American College of Cardiology for High-Quality Heart Failure and Acute Myocardial Infarction CareRishi K Wadhera, Muthiah Vaduganathan, Ginger Y Jiang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 12, 2018
Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS MetastasesJessica J Lin, Ginger Y Jiang, Nencyben Joshipura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung CancerJessica J Lin, Viola W Zhu, Satoshi Yoda, et al.Pageof 1